MA. ANTONIA
SALUD SALVIA
TEU
Hospital Ernest Lluch de Calatayud
Calatayud, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Ernest Lluch de Calatayud (1)
2010
-
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
Chemotherapy, Vol. 56, Núm. 2, pp. 142-146